2005
DOI: 10.1517/14712598.5.12.1557
|View full text |Cite
|
Sign up to set email alerts
|

Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours

Abstract: Nanoscale polymer carriers have the potential to enhance the therapeutic efficacy of antitumour drugs as they can regulate their release, improve their stability and prolong circulation time by protecting the drug from elimination by phagocytic cells or premature degradation. Moreover, nanoscale polymeric carriers are capable of accumulating in tumour cells and tissues due to enhanced permeability and retention effect or by active targeting bearing ligands designed to recognise overexpressed tumour-associated … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
27
0
1

Year Published

2008
2008
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 55 publications
(30 citation statements)
references
References 60 publications
0
27
0
1
Order By: Relevance
“…Given their physical characteristics, these materials are used in the chemical, textile, computing, energy, biomedical and pharmaceutical industries (2), in which nanofibers join other, more established drug nanocarriers (53,54). The most commonly used method for nanofiber production is electrospinning-a widely used modern, versatile and one-step method (Fig.…”
Section: The Role Of Interfacial Rheological Characteristics In the Ementioning
confidence: 99%
“…Given their physical characteristics, these materials are used in the chemical, textile, computing, energy, biomedical and pharmaceutical industries (2), in which nanofibers join other, more established drug nanocarriers (53,54). The most commonly used method for nanofiber production is electrospinning-a widely used modern, versatile and one-step method (Fig.…”
Section: The Role Of Interfacial Rheological Characteristics In the Ementioning
confidence: 99%
“…These delivery vehicles have the potential to augment the pharmacodynamic and pharmacokinetic profiles of drug molecules, thereby enhancing the therapeutic efficacy of the pharmaceutical agents [1]. Further, encapsulating the drug molecule in a delivery system can increase in vivo stability, extend its blood circulation time, and further provide a means for controlling the release of the agent [1]. Moreover, the delivery system can alter the biodistribution of the drug molecule by allowing the agent to accumulate at the tumor site, either passively or actively with targeting [1].…”
Section: Introductionmentioning
confidence: 99%
“…Further, encapsulating the drug molecule in a delivery system can increase in vivo stability, extend its blood circulation time, and further provide a means for controlling the release of the agent [1]. Moreover, the delivery system can alter the biodistribution of the drug molecule by allowing the agent to accumulate at the tumor site, either passively or actively with targeting [1]. In addition to therapeutic drug delivery, serving as diagnostics tools, nanosized carriers can deliver imaging agents to detect and noninvasively diagnose disease.…”
Section: Introductionmentioning
confidence: 99%
“…[219] In addition to nontargeting vector/DNA polyplexes, different vector systems were developed to promote delivery into specific cell populations by incorporation of cell targeting moieties into the vector system. [168,[228][229][230][231] These moieties/ligands (e.g., transferrin, [168,[232][233][234][235][236][237][238][239] epidermal growth factor (EGF), [236,240] arginine-glycine-asparagine (RGD), [241][242][243][244][245] and folate), [242,[246][247][248][249][250] recognize cell type specific receptors in order to direct cellular uptake via receptor-mediated endocytosis, as illustrated in Figure 18. Once bound to the receptors on the cell surface, the vector/DNA polyplexes are internalized by clathrin-dependent endocytosis.…”
Section: Clathrin-mediated Endocytosis (Cme) Is Crucial For Intercellmentioning
confidence: 99%